{"date":"2026-01-01","count":3,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2026-01-01-1936-1jg1kz0","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-01-01","time":"19:36:24","subject":"代重要子公司合富（香港）控股股份有限公司公告最近一年累積處分重要子公司合富中國有價證券達公告標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-01-01 19:36，「代重要子公司合富（香港）控股股份有限公司公告最近一年累積處分重要子公司合富中國有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-01-01-1024-lg5av9","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-01-01","time":"10:24:07","subject":"代重要子公司Belite Bio, Inc公告完成現金增資(補充公告)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-01-01 10:24，「代重要子公司Belite Bio, Inc公告完成現金增資(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2026-01-01-0003-1bkm0mx","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-01-01","time":"00:03:13","subject":"公告本公司代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-01-01 00:03，「公告本公司代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}